Insulet Corporation   Report issue

For profit Phase 3
Founded: Bedford MA United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2015
NCT02561078
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Insulet Corporation

Active Ingredients

Drugs in Phase 3 Trials (1)

insulin human (humulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1